Liquent - Comment

Document ID: FDA-2011-N-0724-0009
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: December 27 2011, at 12:00 AM Eastern Standard Time
Date Posted: January 5 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: October 26 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: December 27 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f89f90
View Document:  View as format xml

View Comment

Please see attached file

Attachments:

Liquent Comments regarding US M1 v2

Title:
Liquent Comments regarding US M1 v2

View Attachment: View as format pdf

Related Comments

    View All
Total: 8
MacroGenics, Inc. - Comment
Public Submission    Posted: 01/05/2012     ID: FDA-2011-N-0724-0004

Dec 27,2011 11:59 PM ET
Pharmaceutical Research and Manufacturers of America (PhRMA) - Comment
Public Submission    Posted: 01/05/2012     ID: FDA-2011-N-0724-0006

Dec 27,2011 11:59 PM ET
IRISS - Comment
Public Submission    Posted: 01/05/2012     ID: FDA-2011-N-0724-0007

Dec 27,2011 11:59 PM ET
Biologics Consulting Group - Comment
Public Submission    Posted: 01/05/2012     ID: FDA-2011-N-0724-0008

Dec 27,2011 11:59 PM ET
Liquent - Comment
Public Submission    Posted: 01/05/2012     ID: FDA-2011-N-0724-0009

Dec 27,2011 11:59 PM ET